ALGEN — genOway SA Cashflow Statement
0.000.00%
Last trade - 00:00- €29.70m
- €30.33m
- €22.06m
- 81
- 53
- 42
- 62
Annual cashflow statement for genOway SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | — | — | FAS | FAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -0.687 | -0.323 | 0.778 | 1.57 | — |
| Depreciation | |||||
| Non-Cash Items | -0.122 | -0.347 | -0.183 | -2.06 | — |
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.739 | -1.99 | -0.975 | -0.73 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.164 | -0.561 | 2.36 | 3.06 | — |
| Capital Expenditures | -4.52 | -2.28 | -1.92 | -1.78 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.23 | 0.013 | -0.025 | -0.215 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.75 | -2.26 | -1.94 | -2 | — |
| Financing Cash Flow Items | 1.04 | 4.42 | 0 | -0.073 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.54 | 5.71 | -1.14 | -1.69 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.63 | 2.89 | -0.727 | -0.622 | — |